For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.
Dr. Daniel Meltzer, a weight loss expert, suggests that it's possible to maintain weight loss after using GLP-1 medications by creating proper habits, including exercise and eating well. He emphasizes ...
Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based ...
HealthDay News — For people with diabetes, the use of glucagon-like ... as well as a control group that continued use of non-GLP-1 RA antihyperglycemics (usual care; 1,203,097 individuals).
NEW YORK, Jan. 22 (UPI) --As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a new study has uncovered neurological and behavioral health ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may ... sleep disturbances and non-infectious gastroenteritis, which is inflammation of the digestive tract which ...
Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback